Search Results - "Harb, W.A." :: K.UTB vyhledávací portál

36O 99MTC-ETARFOLATIDE (EC20) IMAGING TO IDENTIFY NSCLC PATIENTS LIKELY TO BENEFIT FROM VINTAFOLIDE (EC145) TREATMENT

by Harb, W.A, Bonomi, P, Symanowski, J, Nguyen, B, Edelman, M
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2013)

Get full text

Journal Article

Loading…

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)

by Morris, R.T., Joyrich, R.N., Naumann, R.W., Shah, N.P., Maurer, A.H., Strauss, H.W., Uszler, J.M., Symanowski, J.T., Ellis, P.R., Harb, W.A.
Published in Annals of oncology (01.04.2014)

Get full text

Journal Article

Loading…

1171PREAL-TIME IDENTIFICATION OF LUNG ADENOCARCINOMA TUMOR LESIONS LIKELY TO RESPOND TO VINTAFOLIDE TREATMENT BY USING ETARFOLATIDE

by Garon, E.B., Harb, W.A., Bonomi, P., Yao, S., Nguyen, B., Mogg, R., Edelman, M.J.
Published in Annals of oncology (01.09.2014)

Get full text

Journal Article

Loading…

481PPHASE 1 DOSE-ESCALATION STUDY OF THE FOLIC ACID-TUBULYSIN SMALL-MOLECULE DRUG CONJUGATE EC1456 IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS

by Sausville, E.A., Harb, W.A., Ramanathan, R.K., Leamon, C.P., Reddy, J.A., Clark, R., Matei, D.E.
Published in Annals of oncology (01.09.2014)

Get full text

Journal Article

Loading…

Phase 1 Dose-Escalation Study of the Folic Acid-Tubulysin Small-Molecule Drug Conjugate Ec1456 in Patients (Pts) with Advanced Solid Tumors

by Sausville, E.A., Harb, W.A., Ramanathan, R.K., Leamon, C.P., Reddy, J.A., Clark, R., Matei, D.E.
Published in Annals of oncology (01.09.2014)

Get full text

Journal Article

Loading…

Real-Time Identification of Lung Adenocarcinoma Tumor Lesions Likely to Respond to Vintafolide Treatment By Using Etarfolatide

by Garon, E.B., Harb, W.A., Bonomi, P., Yao, S., Nguyen, B., Mogg, R., Edelman, M.J.
Published in Annals of oncology (01.09.2014)

Get full text

Journal Article

36O 99MTC-ETARFOLATIDE (EC20) IMAGING TO IDENTIFY NSCLC PATIENTS LIKELY TO BENEFIT FROM VINTAFOLIDE (EC145) TREATMENT

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)

1171PREAL-TIME IDENTIFICATION OF LUNG ADENOCARCINOMA TUMOR LESIONS LIKELY TO RESPOND TO VINTAFOLIDE TREATMENT BY USING ETARFOLATIDE

481PPHASE 1 DOSE-ESCALATION STUDY OF THE FOLIC ACID-TUBULYSIN SMALL-MOLECULE DRUG CONJUGATE EC1456 IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS

Phase 1 Dose-Escalation Study of the Folic Acid-Tubulysin Small-Molecule Drug Conjugate Ec1456 in Patients (Pts) with Advanced Solid Tumors

Real-Time Identification of Lung Adenocarcinoma Tumor Lesions Likely to Respond to Vintafolide Treatment By Using Etarfolatide

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database